Author:
Schuck Robert N.,Delfino Jana G.,Leptak Christopher,Wagner John A.
Reference80 articles.
1. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework;Biomarkers Definitions Working Group;Clin Pharmacol Ther,2001
2. BEST (biomarkers, endpoints, and other tools) resource [internet];FDA-NIH Biomarker Working Group,2016
3. Estimation of clinical trial success rates and related parameters;Wong;Biostatistics,2019
4. The value, qualification, and regulatory use of surrogate end points in drug development;Lathia;Clin Pharmacol Ther,2009
5. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial;Echt;N Engl J Med,1991
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献